Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Kieler

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The FEBS Journal|January 18, 2021
More than just protein building blocks: how amino acids and related metabolic pathways fuel macrophage polarizationMarkus Kieler, Melanie Hofmann, Gernot Schabbauer
Pancreas|January 19, 2018
Challenges and Perspectives for Immunotherapy in Adenocarcinoma of the Pancreas: The Cancer Immunity CycleMarkus Kieler, Matthias Unseld, Daniela Bianconi, et al.
Memo|October 10, 2017
Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancerMarkus Kieler, Matthias Unseld, Daniela Bianconi, et al.
Therapeutic Advances in Medical Oncology|July 31, 2019
A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acidMarkus Kieler, Matthias Unseld, Daniela Bianconi, et al.
Theranostics|April 21, 2020
3D approaches to model the tumor microenvironment of pancreatic cancerElena Tomás-Bort, Markus Kieler, Shreya Sharma, et al.
Parkinsonism & Related Disorders|June 4, 2017
Task-dependent variability of Essential TremorNicole Schuhmayer, Corinna Weber, Markus Kieler, et al.
Journal of Cancer|May 6, 2022
Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell BehaviorDaniela Bianconi, Elisabeth Fabian, Merima Herac, et al.
ESMO Open|March 4, 2017
Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky diseaseMarkus Kieler, Werner Scheithauer, Christoph C Zielinski, et al.
Oncology|February 15, 2018
Analysis of 10 Adrenocortical Carcinoma Patients in the Cohort of the Precision Medicine Platform MONDTIMarkus Kieler, Leonhard Müllauer, Oskar Koperek, et al.
Medical Oncology (Northwood, London, England)|November 15, 2018
Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapyMarkus Kieler, Matthias Unseld, Johann Wojta, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The FEBS Journal|January 18, 2021
More than just protein building blocks: how amino acids and related metabolic pathways fuel macrophage polarizationMarkus Kieler, Melanie Hofmann, Gernot Schabbauer
Pancreas|January 19, 2018
Challenges and Perspectives for Immunotherapy in Adenocarcinoma of the Pancreas: The Cancer Immunity CycleMarkus Kieler, Matthias Unseld, Daniela Bianconi, et al.
Memo|October 10, 2017
Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancerMarkus Kieler, Matthias Unseld, Daniela Bianconi, et al.
Therapeutic Advances in Medical Oncology|July 31, 2019
A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acidMarkus Kieler, Matthias Unseld, Daniela Bianconi, et al.
Theranostics|April 21, 2020
3D approaches to model the tumor microenvironment of pancreatic cancerElena Tomás-Bort, Markus Kieler, Shreya Sharma, et al.
Parkinsonism & Related Disorders|June 4, 2017
Task-dependent variability of Essential TremorNicole Schuhmayer, Corinna Weber, Markus Kieler, et al.
Journal of Cancer|May 6, 2022
Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell BehaviorDaniela Bianconi, Elisabeth Fabian, Merima Herac, et al.
ESMO Open|March 4, 2017
Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky diseaseMarkus Kieler, Werner Scheithauer, Christoph C Zielinski, et al.
Oncology|February 15, 2018
Analysis of 10 Adrenocortical Carcinoma Patients in the Cohort of the Precision Medicine Platform MONDTIMarkus Kieler, Leonhard Müllauer, Oskar Koperek, et al.
Medical Oncology (Northwood, London, England)|November 15, 2018
Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapyMarkus Kieler, Matthias Unseld, Johann Wojta, et al.
Pageof 4